Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008 Nov 01; 26(31):5043-51.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Observation
Paclitaxel
Patient Selection
Pneumonectomy
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome
United States

authors with profiles

Richard Schilsky
Everett E. Vokes